New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
OverviewChart

Quote Panel

Shape
Updated July 2, 2025
1W % 1M % 3M % 1Y %

Key Metrics

Shape

  • Market Cap

  • Shares Outstanding

  • Share in Float

  • Dividende

  • Earning Date

    No Data

  • Price Target

  • Average Volume

  • Beta

  • Range

  • Industry

  • Website

  • Sector

Fundamentals

Shape

Relative Strength

Shape

HCC

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$2B

Shape480%

2026-Revenue

$4.08

Shape2649%

2026-EPS

$600M

Shape3552%

2026-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Hold

Price Target

0.00(-100.00%)

Number of analyst

0

Last analyst upgrade/downgrade

Citigroup

upgrade

Previous: Not converted

2024-04-11

Now: Buy

B. Riley Securities

upgrade

Previous: Not converted

2022-09-23

Now: Buy

BMO Capital

downgrade

Previous: Not converted

2022-08-03

Now: Market Perform

Jefferies

upgrade

Previous: Not converted

2022-06-07

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q2.23

arrow
arrow

-72%

1.63
vs 5.87

Q3.23

arrow
arrow

-12%

1.85
vs 2.1

Q4.23

arrow
arrow

+31%

2.49
vs 1.9

Q1.24

arrow
arrow

-26%

2.63
vs 3.57

Q2.24

arrow
arrow

-17%

1.35
vs 1.63

Q3.24

arrow
arrow

-57%

0.8
vs 1.85

Q4.24

arrow
arrow

-94%

0.15
vs 2.49

Q1.25

arrow
arrow

N/A

-0.16
vs 2.63

Q2.25

arrow
arrow

N/A

-0.26
vs 1.35

Q3.25

arrow
arrow

-22%

0.62
vs 0.8

Sales GrowthShape

status-upYoY

Current

Estimates

Q2.23

arrow
arrow

-39%

379.7M  vs 625.2M

Q3.23

arrow
arrow

+9%

423.5M  vs 390.2M

Q4.23

arrow
arrow

+6%

363.8M  vs 344.8M

Q1.24

arrow
arrow

-1%

503.5M  vs 509.7M

Q2.24

arrow
arrow

+4%

396.5M  vs 379.7M

Q3.24

arrow
arrow

-23%

327.7M  vs 423.5M

Q4.24

arrow
arrow

-18%

297.5M  vs 363.8M

Q1.25

arrow
arrow

-40%

299.9M  vs 503.5M

Q2.25

arrow
arrow

-28%

284.7M  vs 396.5M

Q3.25

arrow
arrow

+4%

339.9M  vs 327.7M

Return on EquityShape

status-upQoQ

Q2.23

arrow
arrow

+5%

0.05
vs 0.12

Q3.23

arrow
arrow

+5%

0.05
vs 0.05

Q4.23

arrow
arrow

+7%

0.07
vs 0.05

Q1.24

arrow
arrow

+7%

0.07
vs 0.07

Q2.24

arrow
arrow

+3%

0.03
vs 0.07

Q3.24

arrow
arrow

+2%

0.02
vs 0.03

Q4.24

arrow
arrow

+0%

0
vs 0.02

Q1.25

arrow
arrow

0%

-0.00
vs 0

Institutionnal OwnershipShape

status-upQoQ

Q2.23

arrow
arrow

246

246
vs 233

6%

Q3.23

arrow
arrow

258

258
vs 246

5%

Q4.23

arrow
arrow

294

294
vs 258

14%

Q1.24

arrow
arrow

322

322
vs 294

10%

Q2.24

arrow
arrow

308

308
vs 322

-4%

Q3.24

arrow
arrow

284

284
vs 308

-8%

Q4.24

arrow
arrow

288

288
vs 284

1%

Q1.25

arrow
arrow

266

266
vs 288

-8%

Earnings Growth

Latest News

HCC

globenewswire.com

8 hours ago

Tempest Receives Clearance to Proceed with Pivotal Trial of Amezalpat Combination Therapy for First-Line HCC in China
HCC

globenewswire.com

8 hours ago

Tempest Receives Orphan Drug Designation from the European Medicines Agency for Amezalpat for the Treatment of Patients with HCC
HCC

globenewswire.com

8 hours ago

Hepion Pharmaceuticals Executes Binding Letter of Intent with New Day Diagnostics to Commercialize Diagnostic Tests for Celiac Disease, Respiratory Multiplex, H. Pylori and HCC
HCC

marketwatch.com

11 hours ago

Steel, not energy, is key to coal's future growth. Here's why.
HCC

globenewswire.com

12 hours ago

Tokio Marine HCC and Susan G. Komen® Team Up Once Again with Golf Champion Nelly Korda to Help End Breast Cancer
HCC

businesswire.com

23 hours ago

Somerset International Installs Six Tailings Dewatering Units at Warrior Met Coal's Blue Creek Mine, the Largest U.S. Coal Facility Without a Tailings Dam